At United BioChannels we deliver the strategy and support required for our Brands and their investors to bring innovations to market.
Brand awareness within the life science ecosystem targeting researchers, pharmaceutical companies, and investors.
Rapid revenue growth utilizing established agent channels and regional business development consultants.
Business forecasting, channel transparency, and regular business review.
“United BioChannels enables me to stay focused on providing excellent customer service. Their brands offer value to my clients by providing cutting edge technology, the technical resources to apply it and commercial support consistent with a National sales office.”
– Vijay Bhakta, Manufacturer’s Representative
“UBC provided a network of skilled business development representatives helping us expand our reach into North American. Their market knowledge, familiarity with the US sales process and direct working knowledge of our key customers accelerated our sales under an affordable structure.”
– Iain McWilliam, PhD, CEO, Arrayjet Ltd
United BioChannels specializes in developing and implementing sales and marketing strategies for life science companies entering the North American market.
Our team of experienced regional business development consultants work with our network of sales agents and marketing partners to accelerate your products’ introduction. We excel in establishing and managing sales channels by matching products with appropriate agents within an economical cost structure. Unlike distribution models we provide marketing feedback, customer access, and visibility to the end user.
News and Resources
As part of their Series C financing, Biodesy has dedicated funds to expanding commercial efforts. Over the last four months the company has partnered with United BioChannels, a life science brand management company, to explore applications and customer...read more
Nanomedical Diagnostics Agile R100 Graphene Biosensor Characterizes Difficult-to-Study MYC Oncoprotein for Cancer Research
Using data gathered by Agile R100, a kinetic binding assay system, scientists from Dr. Kim Janda’s laboratory at the Scripps Research Institute developed a new series of compounds with the potential to down-regulate the transcriptional activities of MYC....read more
Nanomedical Diagnostics Launches New Graphene Biosensor for Validating Primary Screen Hits During Early Stage Drug Discovery
Nanomedical Diagnostics, leading manufacturer of graphene biosensors that accelerate pharmaceutical development, launches the new Super Amine-Immobilization Biosensor – SCOOH, for use with the company’s optics-free assay troubleshooting system, Agile R100. The new...read more